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ABSTRACT
For mouse embryonic stem (ES) cells, the importance of the
Sa n dG 2 cell cycle checkpoints for genomic integrity is
increased by the absence of the G1 checkpoint. We have
investigated ionizing radiation (IR)-mediated cell cycle
checkpoints in undifferentiated and retinoic acid-differenti-
ated human embryonal carcinoma (EC) cells. Like mouse
ES cells, human EC cells did not undergo G1 arrest after
IR but displayed a prominent S-phase delay followed by a
G2-phase delay. In contrast, although differentiated EC cells
also failed to arrest at G1-phase after IR, they quickly exited
S-phase and arrested in G2-phase. In differentiated EC cells,
the G2-M-phase cyclin B1/CDC2 complex was upregulated
after IR, but the G1-S-phase cyclin E and the cyclin E/
CDK2 complex were expressed at constitutively low levels,
which could be an important factor distinguishing DNA
damage responses between undifferentiated and differenti-
ated EC cells. S-phase arrest and expression of p21 could be
inhibited by 7-hydroxystaurosporine, suggesting that the
ataxia-telangiectasia and Rad-3-related-checkpoint kinase 1
(ATR-CHK1), and p21 pathways might play a role in the
IR-mediated S-phase checkpoint in EC cells. IR-mediated
phosphorylation of ataxia-telangiectasia mutated, (CHK1),
and checkpoint kinase 2 were distinctly higher in undiffer-
entiated EC cells compared with differentiated EC cells.
Combined with the prominent S and G2 checkpoints and a
more efﬁcient DNA damage repair system, these mecha-
nisms operate together in the maintenance of genome stabil-
ity for EC cells. STEM CELLS 2009;27:568–576
Disclosure of potential conﬂicts of interest is found at the end of this article.
INTRODUCTION
Embryonic stem (ES) cells are deﬁned as having the capacity
for both self-renewal and differentiation [1, 2]. Such a unique
capacity enables ES cell to proliferate extensively while main-
taining the potential to differentiate into a wide variety of cell
types. Compared with somatic cells, ES cells have many un-
usual proliferative properties [3], one of which is a distinct
cell cycle distribution with a large proportion of cells (approx-
imately 60%) in S-phase and 20% of cells in G1- and G2-
phase in mouse and primate ES cells [4–7]. The cell cycle
timing of ES cells also differs from that of somatic cells: the
average cell cycle time of a 6.25-dpc epiblast is 9.1 hours and
that of a mouse ES cell is 11 hours, compared with NIH3T3
cells (22.1 hours), and mouse embryonic ﬁbroblasts (25.3
hours) [4]. Human ES cells (line H1) also have a shortened
G1 (2.5-3 hours) and 65% of growing cells are in S-phase,
with duration of S-, G2-, and M-phase being 8, 4, and 1
hours, respectively [8]. As ES cells differentiate, their cell
cycle changes signiﬁcantly to incorporate a longer G1-phase.
Thus, ES cells seem to have an extremely rapid cell division,
which is due in part to an atypical cell cycle that lacks gap
phases and consists mainly of S-phase and M-phase [4]. In
murine ES (mES) cells, pRb and p107 are held in a hyper-
phosphorylated state and do not associate with the E2F family
of transcription factors [4, 9]. Therefore, the lack of inhibition
of E2F by pRb may account for the short G1 period of ES
cells. When ES cells differentiate, pRb control on G1 is
imposed, which coincides with the establishment of cell cycle
regulated cyclin-dependent kinase (CDK) activities [4, 3].
Human ES cells show a decreased dependence on E2F/pRb
pathway in regulation of G1- to S-phase transition [10], and
they express all G1-related cyclins (D1, D2, D3, and E) and
CDKs (CDK2, CDK4, and CDK6) [11]. In particular, high
mRNA level of cyclin D2/CDK4 may contribute to rapid G1
progression of human ES cells [8].
Somatic cells respond to DNA damage at different phases
of the cell cycle by activating sets of checkpoint pathways.
As cell cycle arrest in G1 prevents cells with damaged DNA
from entering S-phase [12], the G1 DNA damage checkpoint
is an important mechanism for maintaining genome stability
in somatic cells. However, pluripotent cells in mice and pri-
mates do not undergo G1 growth arrest after DNA damage [6,
7, 13]. A short G1-phase and the absence of a DNA damage-
mediated G1 checkpoint are thus unique cell cycle
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distinct cell cycle regulation in ES cells: (a) an inactive pRb-
E2F pathway [3, 4, 9]; (b) low expression of cyclin D1 [3, 4];
and (c) absence of stress-induced transactivation of p21 [14].
In somatic cells, the S-phase checkpoint is crucial because
S-phase is a last line of defense before DNA lesions are con-
verted into heritable mutations: each lesion will inevitably be
encountered by the replication machinery and stall DNA rep-
lication forks [12]. The G2 checkpoint provides extra time to
repair and remove DNA lesions before they are passed on to
daughter cells [12]. In general, activation of the ataxia-telan-
giectasia mutated/ataxia-telangiectasia and Rad-3-related-
checkpoint kinase 1/checkpoint kinase 2-cell division cycle 25
homolog A (ATM/ATR-CHK1/CHK2-CDC25A) pathway
mediates inactivation of the S-phase cyclin E/CDK2 com-
plexes and S-phase arrest [15], and the ATM/ATR-CHK1/
CHK2-CDC25C pathway mediates G2-phase arrest by main-
taining the inactive form of the cyclin B1/CDK1 complex
[16, 17]. In ES cells, the absence of a G1 cell cycle check-
point has been relatively well-studied. It has also been found
that decatenation checkpoint is defective in mES cells and
human CD34
þ progenitor cells [18], resulting in chromosome
missegregation in these cells. Thus, the lack of a G1 check-
point and ineffectiveness of decatenation checkpoint increase
the importance of S and G2 DNA damage checkpoints for
genomic integrity in stem cells, which so far are not well-
understood. Jirmanova et al. showed that p38a kinase played
a critical role for normal S-phase function in mouse ES cells
when the ATR/CHK1 pathway is inhibited [19]. However,
this study was limited to the caffeine-induced S-phase check-
point [19]. Recently, p21 has been found to rapidly increase
in response to IR in human ES cells, which may further alter
E2F/pocked proteins and Histone H4 gene expression. How-
ever, it is limited at mRNA level, and how the altered gene
expressions affect cell cycle progression is still unclear [20].
ES cells must maintain sufﬁcient genomic integrity to
pass an intact genome to the next generation [21]. The DNA
repair pathways are involved in successful mammalian game-
togenesis and embryo development, with many important
DNA repair genes expressed in the early stages of mammalian
development [22]. Deﬁciency in DNA repair genes is associ-
ated with increased rates of birth defects, cancer, and reduced
lifespan [23]. Recent evidence indicates that deﬁciency in
DNA repair leads to hematopoietic stem cell ageing with loss
of reconstitution and proliferation potential [24]. Another pro-
tective mechanism of ES cells is their lack of a G1 checkpoint
following DNA damage. Instead of G1 cell cycle arrest, ES
cells are prone to undergo apoptosis (increases in apoptosis of
40%) to prevent cells with damaged genomes from contribut-
ing to the developing organism [6, 14, 25]. Therefore, multi-
ple mechanisms including DNA damage detection, DNA
repair, cell cycle arrest, and apoptosis operate together to pro-
tect genome stability during embryo development [23].
Previous studies of the cell cycle and checkpoints of stem
cells have largely been carried out in vitro using ES cell lines.
In the presence of leukemia inhibitory factor (LIF), mES cells
can be maintained in culture indeﬁnitely as a stem cell popu-
lation that resemble the pluripotent cell population of the
inner cell mass (ICM); thus, mES cells cycle with kinetics
comparable with their counterpart in the embryonic epiblast
[4, 9]. Although human ES cells are not LIF-dependent in
culture, it is believed that the basic cell cycle control mecha-
nisms might be conserved between mouse and human ES
cells [9]. The NCCIT cell line used in this study is a pluripo-
tent embryonal carcinoma (EC) cell line, which is capable of
somatic and extraembryonic differentiation [26]. In vitro,
these cells can differentiate in response to retinoic acid (RA)
[27]. Although EC and ES cells are derived from different
sources of embryo, in culture system, EC cells have some
similarities to ES cells in terms of karyotypic changes, adap-
tation to culture, and teratotumor formation [28]. EC cells are
pluripotent, but they might proliferate in a hierarchical stem
cell pattern, which could be a limitation for the study of stem
cell cycle structure [29].
Rapid proliferation with a high proportion of cells in S-
phase is one of the distinct features of stem cells; therefore,
the presence of DNA damage-mediated S and G2 checkpoints
and the regulation of these checkpoints in stem cells are not
well understood. In this study, we compared DNA damage
mediated S and G2 checkpoints in undifferentiated and differ-
entiated human EC cells.
MATERIALS AND METHODS
Cell Culture and Treatments
Human pluripotent EC cells (line NCCIT from ATCC, Manassas,
VA, http://www.atcc.org) were cultured in RPM/1640 medium
(Invitrogen, Gibco, Carlsbad, CA, http://www.invitrogen.com) con-
taining 10% FBS (Invitrogen) according to ATCC instructions. All
experiments were performed in parallel in undifferentiated EC and
differentiated EC counterparts. For somatic differentiation of EC
cells, 10 lM RA (Sigma, St. Louis, MO, http://www.sigmaaldrich.
com) was added to cultures for 7 days with addition of fresh 10
lM of RA at each medium change. Ionizing radiation (IR) was
delivered by exposing cells to Cs
137 in a Gammacell 3,000 (MDS
Nordion, Germany). The checkpoint inhibitor 7-hydroxystaurospor-
ine (UCN-01) was kindly provided by Developmental Therapeutics
Program, National Cancer Institute (NCI, Bethesda, MD).
Flow Cytometric Cell Cycle Analysis
Cells were seeded at a density of 4-5   10
5 at least 24 h before
experiments. Cells were mock-irradiated or c-irradiated with 4, 6,
or 15 Gy and incubated for the indicated time. The DNA content
of propidium iodide (Sigma) stained cell nuclei was determined
using a FACScan (Becton Dickinson, San Jose, CA, http://
www.bd.com) and data acquisition was performed with CellQuest
(Becton Dickinson) software. The percentages of cells in G1-, S-,
and G2/M-phase were calculated using ModFit software (Verity
Software House, Topsham, ME). For 5-bromo-20-deoxyuridine
(BrdU) incorporation analysis, cells were pulsed with 10 lM
BrdU (Sigma) for 30 minutes before harvesting and ﬁxed in 80%
cold ethanol. BrdU content was determined by a FITC-conjugated
anti-BrdU antibody (Becton Dickinson) according to the manu-
facturer’s instructions. Propidium iodide-RNase (Sigma) counter-
staining was used to determine DNA content.
Antibodies and Western Blots
Antibodies against cyclin A, E, B1, CDC25A, CDK2, CDC2,
p21, p27, and p53 were obtained from Santa Cruz Biotechnology
Inc. (Santa Cruz, CA, http://www.scbt.com). Antibodies against
phospho-ATM (Ser1981), phospho-CHK1 (Ser345), phospho-
CHK2 (Thr68), phospho-CDC25C (Ser216), phospho-p53
(Ser15), phospho-CDC2 (Tyr15), and cleaved caspase three were
from Cell Signaling Technology (Beverly, MA, http://www.cell-
signal.com). OCT4 antibody was purchased from Chemicon,
Millipore (Billerica, MA, http://www.millipore.com). Ten to
30 lg of total protein lysates were loaded and separated on 10%
or 12% acrylamide gels and transferred to PVDF membranes.
Membranes were incubated with primary antibody overnight at
4 C, HRP-conjugated secondary antibody for 1 hour at room tem-
perature, and protein expression was revealed with ECL reagents
(Amersham, GE healthcare UK Limited, U.K., http://
www.gehealthcare.com).
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Total cell lysates (200 lg) were incubated with 2 ll of primary
antibody for immunoprecipitation on ice for 1-2 hours, then incu-
bated with 30 ll protein G sepharose (Amersham Biosciences,
Sweden, http://www.gehealthcare.com) for 1 hour followed by
three washes with lysis buffer. The immune complexes were col-
lected and dissolved in SDS sample buffer for Western blots.
Immunoﬂuorescence
Undifferentiated and RA-induced differentiated NCCIT cells were
seeded and grown for more than 24 hours followed by exposure
to 3 Gy of IR. At 0, 1.5, and 30 hours, cells were cyto-spun onto
gelatinized slides. Cells were ﬁxed in 4% paraformaldehyde, per-
meabilized with 0.25% Triton X-100 in PBS, and incubated with
antibody (phospho-H2AX Ser139, Cell Signaling Technology,
Beverly, MA, http://www.cellsignal.com) at 4 C overnight. Cells
were then incubated with FITC-conjugated secondary antibody
(Sigma) for 1 hour. Images were captured with a Nikon micro-
scope system. The numbers of cH2AX foci per cell of 1,000 cells
from two independent experiments were scored.
Colony Forming and Cell Viability Assays
Undifferentiated and RA-differentiated EC cells were seeded at a
density of 5,000-7,000 cells per 5-cm culture dish. After 40 hours, the
cells were exposed to 0, 0.5, 1, or 1.5 Gy of IR. After incubating for
another 7 days, colonies were stained by velvet blue and quantiﬁed.
For cell viability assays, cells were seeded at 1   10
4 per well in 96-
well plates and incubated with 2-(2-methoxy-4-nitrophenyl)-3-(4-
nitro-phenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (Cell Count-
ing Kit-8, Dojindo Lab, Japan, http://www.dojindo.com)
following manufacturer instructions. The formazan dye generated
by the activity of dehydrogenases was measured at 450 nm ab-
sorbance and was proportional to the number of living cells.
TUNEL Assays
For TUNEL analysis, a ﬂuorescence-conjugated in situ cell death
detection kit (Roche Diagnostics, Mannheim, Germany, https://
www.roche-applied-science.com) was used following the manu-
facturer’s instructions. A total of 1,000-1,500 cells were scored to
calculate the percentage of apoptotic cells.
RESULTS
Different IR-Mediated Cell Cycle Checkpoints in
Undifferentiated and Differentiated EC Cells
The absence of a DNA damage-mediated G1 cell cycle check-
point has been observed in mouse ES cells [6, 13], bringing up
the question of what machinery ES cells employ for to protect
genome stability. Using human EC NCCIT cells as a model,
we investigated how human EC cells respond to IR-mediated
DNA damage. In parallel, DNA damage checkpoint functions
were compared with differentiated EC cells. In an asynchro-
nous population, human EC cells displayed a cell cycle phase
distribution (Fig. 1A, 1C) that was similar to mouse ES cells
[9]. Following 6 Gy of IR, the undifferentiated EC cells did
not arrest in G1-phase. Instead, the cells displayed a prominent
S-phase delay (87.5%   3.5%) at 16 hours post-IR, followed
by a G2-phase delay (83%   0.79%, 66%   4.2%) at 24 and
30 hours post-IR (Fig. 1A, 1C). Using BrdU labeling, we found
that EC cells exhibited a high basal line of S-phase; this frac-
tion was further increased in response to IR, before gradually
moving into G2-/M-phase (Fig. 1D).
In contrast, RA-induced differentiated EC cells quickly
exited S-phase and arrested in G2 after DNA damage. The S-
phase fraction was 32.5%   2.2% at 0 hour, 21%   1.3% at
16 hours, 16%   8.5% at 24 hours, and 13.5%   0.7%,
whereas the G2 fraction increased from 13.8%   0.2% at
0 hour to 68%   1.2% at 16 hours, 69%   3.5% at 24 hours,
and 67%   1.4% at 30 hours (Fig. 1B, 1C, 1D). Thus, in
response to IR, both undifferentiated and differentiated EC
cells displayed a G2 arrest response, but undifferentiated EC
cells displayed an S delay before they arrested at G2-phase.
There was a complete lack of IR-mediated G1 cell cycle
delay from 6 to 30 hours after IR in human EC cells (Fig.
1A, 1C). BrdU labeling further veriﬁed the absence of a G1
population in undifferentiated EC cells after IR (Fig. 1D).
These results suggest that the lack of a functional G1 damage
checkpoint is a common phenomenon in pluripotent cells
from mice [6, 13], primates [7], and humans. Moreover,
although the G1 population increased when the EC cells dif-
ferentiated (54%   2% in differentiated EC cells vs. 29%  
0.8% in undifferentiated EC cells; Fig. 1A, 1B), there was no
obvious G1 growth arrest after IR DNA damage (Fig. 1B, 1C,
1D), indicating that RA-induced differentiation could not es-
tablish the G1 checkpoint in EC cells.
Distinct Regulation of Cyclin E/CDK2
After DNA Damage in Undifferentiated and
Differentiated EC Cells
The above data indicate that although human EC cells lacked
the G1 DNA damage checkpoint, they seemed to have intact S
and G2 checkpoints. When EC cells became differentiated, the
ability of the cells to undergo IR-mediated S-phase delay was
attenuated and G2-phase arrest became prominent. We then
asked whether there is any difference in the cell cycle machin-
ery between undifferentiated and differentiated human EC
cells, which might differentially regulate cell cycle checkpoints.
First, there were large differences in the absolute levels of
cyclins between undifferentiated and differentiated EC cells.
Undifferentiated EC cells expressed high levels of cyclin A,
cyclin E, and cyclin B1. The levels of these cyclins decreased
dramatically after differentiation (Fig. 2A, at zero timepoint).
This phenomenon is consistent with observations in mouse and
primate ES cells [3, 7, 9]. OCT4 level was dramatically
reduced or almost depleted in RA-induced EC cells (Fig. 2A),
suggesting that the cells were well differentiated.
We next investigated the expression of cell cycle regulators
in human EC cells after IR-mediated DNA damage. In undif-
ferentiated EC cells, basal levels of cyclin A, E, B1, and
Tyr15-phosphorylated CDC2 were high; they were only
slightly enhanced after IR damage and did not show apparent
periodicity in accordance with cell cycle progress (Figs. 1A,
2A). Examination of other DNA damage checkpoint regulators,
such as phospho-p53 (Ser15), and the CDK inhibitors p21 and
p27, the phosphorylation of p53 on ser15 was normal in both
undifferentiated and differentiated EC cells. p21 level was low
but detectable in both undifferentiated and differentiated cells
(Fig. 2A), unlike previous reports in mouse ES cells that p21
levels are constitutively low [19, 30]. In response to IR, p21
levels clearly increased in undifferentiated cells but not in dif-
ferentiated cells. If p21 indeed has a role in cell cycle arrest, it
might involve in regulation of the S-phase checkpoint but not
induction of a G1 checkpoint. Moreover, although IR-mediated
CDC25A degradation was very minor in undifferentiated EC
cells, it became complete in differentiated EC cells (Fig. 2B).
Phospho-CDC25C (Ser216) was enhanced after IR in both un-
differentiated and differentiated EC cells (Fig. 2B).
In contrast, levels of all the cyclins tested were relatively
low in differentiated EC cells before DNA damage. After IR,
cyclin B1 was signiﬁcantly elevated with a parallel increase in
Tyr15-phosphorylated CDC2 (Fig. 2A) and cyclin B1/CDC2
complex (Fig. 3A). This coincided with a time after IR of 16-
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1D). Likewise, cyclin A level was elevated after DNA damage
(Figs. 2A, 3A). As cyclin E-CDK2 complexes are key regula-
tors of the G1-S transition, we measured cyclin E-associated
CDK2 by coimmunoprecipitation. As shown in Figures 2A and
3B, cyclin E levels were constitutively low and cyclin E bound
to less CDK2 in differentiated EC cells in comparison with un-
differentiated EC cells, particularly absence of responding
enhancement in response to IR indicative of potential distinct
regulation of cyclin E/CDK2 after DNA damage.
Figure 1. Undifferentiated EC cells underwent prominent S-phase delay followed by G2 arrest in response to IR. Undifferentiated and differen-
tiated NCCIT cells were irradiated (6 Gy) followed by ﬂow cytometry analysis of DNA content. Percentages of (A) undifferentiated ( RA) and
(B) differentiated (þRA) NCCIT cells in G1, S, and G2/M cell cycle phase as a function of time after irradiation (means   SD; from three inde-
pendent experiments) were determined using Modﬁt software. (C): Representative histogram of cell cycle distribution in irradiated undifferenti-
ated ( RA) and differentiated (þRA) NCCIT cells at indicated time points. Peaks corresponding to cells with 2n and 4n DNA content were
indicated by arrows. (D): Dot plot representation of PI/BrdU double parameter analysis of irradiated undifferentiated ( RA) and differentiated
(þRA) NCCIT cells at indicated time points. x-axis indicates DNA content and y-axis indicates BrdU positive labeling. Abbreviations: BrdU,
bromodeoxyuridine; IR, ionizing radiation; RA, retinoic acid.
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in Undifferentiated EC Cells
We further compared the activation of components of check-
point pathways between undifferentiated and differentiated
EC cells. Irradiation with 4 Gy or 15 Gy IR rapidly induced
the phosphorylation of ATM, CHK1, CHK2, and p53 in both
undifferentiated and differentiated EC cells (Fig. 4A).
Although the levels of p53 Ser15 phosphorylation were simi-
lar in both types of cells, phosphorylation of ATM, and espe-
cially activation of CHK1 and CHK2, was distinctly higher in
undifferentiated EC cells than in differentiated EC cells (Fig.
4A). These results suggest that undifferentiated EC cells
might be primed to respond to DNA damage. Preferential
checkpoint activation in EC cells indicated a strong protective
mechanism in these cells.
DNA Damage Repair is More Efﬁcient
in Undifferentiated EC Cells
Following double-strand breaks, phosphorylated histone
H2AX (also called cH2AX) forms foci at sites of DNA dam-
age, which serve as platforms to recruit DNA repair proteins
and cell cycle checkpoint proteins such as ATM and CHK2
[31, 32]. We thus determined whether higher checkpoint ac-
tivity in EC cells leads to more efﬁcient DNA damage repair
by monitoring cH2AX foci formation after IR treatment. Un-
differentiated and differentiated EC cells were equally suscep-
tible to IR, with more than 90% of cells forming cH2AX foci
1.5 hours after IR. Most cells displayed 10 or more cH2AX
foci per nucleus (Fig. 4B, 4C). However, DNA damage foci
number was dramatically reduced in undifferentiated EC cells
30 hours after IR. In contrast, the number of cH2AX foci
remained high in differentiated EC cells, with 52.45%  
10.6% of cells displaying >10 cH2AX foci (Fig. 4C). The
relatively higher level of cH2AX remaining in differentiated
EC cells was further conﬁrmed by immunoblotting (Fig. 4D).
Accordingly, the proportion of cells with <10 cH2AX foci
was signiﬁcantly increased in undifferentiated EC cells at
30 hours after IR, indicating that undifferentiated EC cells
repaired DNA damage more efﬁciently than differentiated EC
cells (Fig. 4B, 4C). We noticed that DNA damage foci did
not completely disappear at 30 hours after IR, suggesting that
longer periods may be required for complete repair. Taken
together, these data show that the greater activation of ATM,
CHK1, and CHK2 in undifferentiated EC cells might result in
more efﬁcient DNA damage repair.
Preferential Checkpoint Activation and DNA
Damage Repair as a Protective Mechanism
in Undifferentiated EC Cells
The ability to repair damaged DNA is critical for cell sur-
vival, because unrepaired DNA strand breaks can trigger apo-
ptosis or senescence. We next determined the contributions of
preferential activation of DNA damage checkpoints and DNA
repair capability to cell survival in EC cells. After exposure
to low doses of IR, the survival rates of undifferentiated EC
cells by colony formation were 93.8%, 86%, and 78% at
treatments of 0.5 Gy, 1 Gy, and 1.5 Gy, respectively, whereas
the survival rates of differentiated EC cells were 73%, 55%,
and 45% for the same exposures (Fig. 5A), indicating that un-
differentiated EC cells had relatively higher survival than dif-
ferentiated EC cells after IR treatment.
To examine apoptosis in EC cells, the expression of acti-
vated caspase-3 and the number of apoptotic cells were exam-
ined. Undifferentiated EC cells expressed less activated
Figure 3. Constitutively low levels of cyclin E and cyclin E/CDK2
complex before and after IR in differentiated NCCIT cells. Cells were
untreated or treated with 6 Gy of IR. (A): Cyclin A/CDK2 and cyclin
B1/CDC2 complexes were analyzed by IP for cyclin A then IB for
CDK2; and IP for cyclin B1 then IB for CDC2, respectively. (B):
Cyclin E/CDK2 complexes were analyzed by IP cylin E then IB
CDK2, or IP CDK2 then IB cyclin E. Normal rabbit IgG was used for
control immunoprecipitations. Abbreviations: CDK2, cyclin-dependent
kinase 2; IB, immunobloting; IP, immunoprecipitating; IR, ionizing
radiation; RA, retinoic acid.
Figure 2. Distinct expression of cell cycle-related proteins in undiffer-
entiated and differentiated embryonal carcinoma cells following ionizing
radiation. (A) Western blot analysis of cyclins A, E, and B1, CDK2,
CDC2, phospho-CDC2 (Tyr15), phospho-p53 (Ser15), p21, p27, OCT4,
and (B) CDC25A and phospho-CDC25C (Ser216) at various time points
after irradiation in undifferentiated ( RA) and differentiated (þRA)
NCCIT cells. Abbreviations: CDC25A, cell division cycle 25 homolog
A; CDK2, cyclin-dependent kinase 2; RA, retinoic acid.
572 IR-Mediated S and G2 Checkpoints in Human EC CellsFigure 4. DNA repair is more efﬁcient in undifferentiated embryonal carcinoma cells. (A): Undifferentiated ( RA) and differentiated (þRA)
NCCIT cells were irradiated with 4 or 15 Gy IR. The total and phosphorylated ATM, CHK1, CHK2, and p53 were measured by Western blot.
(B): IR-induced DNA damage foci in undifferentiated ( RA) and differentiated (þRA) NCCIT cells at 0, 1.5, and 30 hours were localized by
immunoﬂuorescence using anti-cH2AX antibody. (C): Quantiﬁcation of the percentage of cells with 0, <10, and >10 cH2AX foci per nucleus at
0, 1.5, and 30 hours after IR (3 Gy) in undifferentiated ( RA) and differentiated (þRA) NCCIT cells. Data represent means   SD from two in-
dependent experiments. (D): Western blot analysis of cH2AX level at 0, 1.5, and 24 hours after IR (3Gy) in undifferentiated ( RA) and differen-
tiated (þRA) NCCIT cells. Abbreviations: ATM, ataxia-telangiectasia mutated; ATMp, phospho-ATM; CHK1, checkpoint kinase 1; CHK1p,
phospho-CHK1; CHK2, checkpoint kinase 2; CHK2p, phospho-CHK2; IR, ionizing radiation; p53p, phospho-p53; RA, retinoic acid.
Figure 5. Undifferentiated EC cells showed better cellular survival after IR than differentiated EC cells. (A): Undifferentiated ( RA) and differen-
tiated (þRA) NCCIT cells were irradiated with 0, 0.5, 1, and 1.5 Gy of IR and cultured for 7 days. Percentages of NCCIT cells capable of colony
formation after irradiation were determined by dividing the number of colonies formed in irradiated cultures by the number of colonies formed in
nonirradiated cultures. Values represent means   SD from two independent experiments and each experiment was performed in triplicate for each
dosage of IR treatment. (B): Total and cleaved caspase three in irradiated and nonirradiated undifferentiated ( RA) and differentiated (þRA)
NCCIT cells (18 hours after IR) were detected by western blot. (C): Apoptotic cells in irradiated and nonirradiated undifferentiated ( RA) and dif-
ferentiated (þRA) NCCIT cells (18 hour after 6 Gy of IR) were detected by TUNEL assay. (D): Percentages of apoptotic cells were determined by
scoring the numbers of TUNEL positive cells in 1,500 cells from two experiments. Abbreviations: DAPI, 40-6-diamidino-2-phenylindole; EC, embry-
onal carcinoma; IR, ionizing radiation; RA, retinoic acid; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling.
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(Fig. 5B). TUNEL assays revealed that undifferentiated EC
cells underwent less apoptosis than differentiated cells after
IR (Fig. 5C). Thus, preferential checkpoint activation and
DNA repair efﬁciency in undifferentiated EC cells might
serve as protective mechanisms in response to DNA damage.
Biological Importance of the S-Phase Checkpoint
Cells possess protective mechanisms including DNA damage
detection, DNA repair, cell cycle arrest, and apoptosis that
operate together to maintain genome integrity. Recent studies
suggest that the same pathways regulating the response to
DNA damage also operate during normal S-phase [23]. Many
types of ES cells, including human EC cells, proliferate
actively with a large fraction of cells in S-phase. The S-phase
population further increased in response to DNA damage in
our experiments. We examined the functional importance of
the S-phase checkpoint by S-phase checkpoint abrogation in
undifferentiated EC cells. UCN-01, a potent ATR-CHK1 path-
way inhibitor, inhibits G2 and S-phase checkpoints in cancer
cell models [33, 34]. As shown in Figure 6A, EC cells were
sensitive to UCN-01: the S-phase delay mediated by 6 Gy of
IR was largely abolished after UCN-01 treatment, indicating
that the ATR-CHK1 pathway was involved in S-phase arrest
in these cells. Although CDC25A degradation was clearly
prevented (Fig. 6B), IR-induced CDC25A degradation was
not complete in undifferentiated EC cells compared with
Figure 6. IR-mediated S-phase arrest in
undifferentiated embryonal carcinoma cells
could be inhibited by UCN-01. Undifferen-
tiated ( RA) and differentiated (þRA)
NCCIT cells were treated with 6 Gy of IR.
UCN-01 (200 nM) was added to the cultures
15 minutes before irradiation. Cells were har-
vested and measured for (A) cell cycle distri-
butions 16 hours after IR; (B) cell cycle and
checkpoint related proteins 2 hours after IR
and UCN-01 alone by Western blot; (C) cell
viability 18 hours after IR by MTT (means
  SD from two independent experiments).
Abbreviations: CHK1p, phospho-CHK1;
CHK2p, phospho-CHK2; CDC25A, cell divi-
sion cycle 25 homolog A; IR, ionizing radia-
tion; RA, retinoic acid; UCN-01, 7-
hydroxystaurosporine.
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CDC25A turnover might not be a major intermediate effector
of the S-phase checkpoint. Interestingly, S-phase regulators,
such as p21 and CDK2, were also signiﬁcantly inhibited by
UCN-01 (Fig. 6B) in undifferentiated but not in differentiated
EC cells; thus, besides the traditional ATR-CHK1-CDC25A
pathway, p21 could play a role in regulating the S-phase
checkpoint in human EC cells, which requires further study.
Moreover, abrogation of S-phase arrest in EC cells resulted in
reduction of cellular survival (Fig. 6C), further indicating the
functional importance of the S-phase checkpoint as a protec-
tive mechanism. In differentiated EC cells, G2 cell cycle
arrest was also sensitive to UCN-01 (Fig. 6A), likely through
inhibition of the ATR-CHK1-CDC25A pathway (Fig. 6B). As
a biological consequence, the abrogation of G2 arrest led to
greater cell death than abrogation of S arrest (Fig. 6C). Thus,
to stem cells, S-phase arrest seemed to be more effective for
cellular protection when cells are subjected to DNA damage.
DISCUSSION
A unique characteristic of cell cycle control in stem cells is a
short G1-phase, with the vast majority of cells in S or G2/M.
This feature has been conserved throughout vertebrate evolu-
tion [7]. Our results indicate that this is also a special feature
of cell cycle control for human EC stem cells (Fig. 1).
Although the mechanisms that allow pluripotent stem cells to
cycle rapidly [4] and devote a high proportion of the cell
cycle (approximately 60%) to S-phase [4] is still unclear, it
could be due to (a) the required ability to divide constitutively
and (b) the consequences of avoiding or shorting G1 to pre-
vent differentiation [4, 35]. These features are further
reﬂected by the failure of stem cells to activate the G1/S
checkpoint after DNA damage. Another interesting result of
the present study is that the G1-phase population increased as
EC cells differentiated. However, this simple differentiation
induced by RA could not establish a complete G1 cell cycle
checkpoint on DNA damage even though damage-induced
ATM (Ser1981), CHK1 (Ser345), CHK2 (Thr68), and p53
(Ser15) phosphorylation appeared to be normal (Fig. 4A).
Therefore, at which stage of development and under what cir-
cumstances the G1 cell cycle checkpoint is necessary for a
cell is still unclear. G1 (or early G1) regulation is thought to
be a sensitive window of cell-fate decision-making in
response to extracellular signals; therefore, ES cells try to
avoid (mES cells) or shorten (hES cells) G1 [35]. It is possi-
ble that the absence of a G1 checkpoint serves a physiological
need for ES cells. If that is the case, the S and G2 cell cycle
checkpoints become crucial in the maintenance of genome in-
tegrity for stem cells.
Our results showed that following IR, undifferentiated
human EC cells had better survival rates (Fig. 5) and more ef-
ﬁcient DNA repair than their differentiated counterparts (Fig.
4). This may in part be due to the enhanced S-phase delay in
undifferentiated EC cells (Fig. 1). When cells lack the G1
DNA damage checkpoint, S-phase and G2 are the only peri-
ods in which cells can arrest the cell cycle to respond to
DNA damage. Indeed, we found IR-mediated G2 arrest in
both undifferentiated and differentiated cells. One conspicu-
ous difference is that undifferentiated EC cells displayed a
prominent S-phase delay before entering G2 arrest. This IR-
mediated S-phase arrest was inhibited by the CHK1 inhibitor
UCN-01, resulting in reduced cell viability (Fig. 6). These
data imply that S-phase arrest may serve as a cellular protec-
tive mechanism. Therefore, the fact that the majority of pluri-
potent EC cells are in S-phase could not only allow for cop-
ing with rapid proliferation, but also provide the machinery
needed for S-phase delay when cells are subjected to DNA
damage. The prominence of S-phase in the cell cycle of stem
cells could provide a checkpoint window for genome integrity
and cellular survival.
Mouse ES cells have constitutive cyclin E-CDK2 activity
that is independent of cell cycle control [4, 9]. The biological
signiﬁcance of this phenomenon is not fully understood. Con-
comitant with hyperphosphorylation and inactivation of RB,
high cyclin E-CDK2 activity effectively reduces the length of
G1-phase. This leads to rapid proliferation, which is postu-
lated to be an important cell cycle regulation for self-renewal
in stem cells [35]. In undifferentiated EC cells, cyclin E/A
and their associated CDK2 were expressed at high levels and
remained high after DNA damage (Figs. 2A, 3). In contrast,
cyclin E and its associated CDK2 levels were much lower in
differentiated EC cells, and without further responding
increase on DNA damage (Figs. 2A, 3B). The different levels
of cyclin E and cyclin E/CDK2 complexes could be important
factors in distinguishing cell cycle features of undifferentiated
from differentiated EC cells.
Our results indicate that the ATR-CHK1-CDC25A path-
way is a signiﬁcant pathway for the G2 DNA damage check-
point, particularly for differentiated EC cells because IR-
induced CDC25A degradation was clearly prevented by the
CHK1 inhibitor UCN-01 (Fig. 6B). However, IR-mediated S-
phase delay in undifferentiated EC cells occurred through the
ATR-CHK1 pathway, but not necessarily the ATR-CHK1-
CDC25A pathway because IR-induced CDC25A degradation
was very minor in these cells (Figs. 2B, 6B). Moreover, we
showed that S-phase-controlling proteins such as p21 and
CDK2 could be inhibited by UCN-01. The CDK inhibitor
p21 is known to regulate CDK2 by associated with cyclin E/
CDK2 and cyclin A/CDK2 complexes [19]. Thus, p21 could
play roles in regulating the S-phase checkpoint for human
EC cells. It would be interesting to explore whether there is
any link between ATR-CHK1 and p21 regulation and the
details of how p21 regulates G1-S-phase cyclins in human
EC cells.
ES cells from mouse, rhesus monkey, and human (e.g.,
the EC cells in the present study) fail to undergo G1 cell cycle
arrest after DNA damage. It has been reported that two mech-
anisms are used to maintain genomic stability after DNA
damage in the absence of a G1 checkpoint in stem cells: (a)
apoptosis to eliminate cells with damaged DNA [6, 7, 25] and
(b) induction of a differentiation program to eliminate cells
with damaged DNA from the stem cell pool [36]. However,
DNA repair genes have been shown to be expressed in the
early stages of mammalian development. In humans, expres-
sion of ATM, BRCA1/2, and TP53 can be detected as early as
the preimplantation embryo [23]. The expression of DNA
repair genes can determine whether or not the embryo sur-
vives following genotoxic stress [23], which would be a more
efﬁcient and applicable mechanism than constantly under-
going apoptosis during the long process of development. Our
results demonstrate that human EC cells displayed normal
activating phosphorylation of ATM, CHK1, CHK2, and p53
(Fig. 4A). Accordingly, EC cells also underwent S and G2
cell cycle arrest in response to IR-induced DNA damage (Fig.
1). More importantly, EC cells displayed efﬁcient DNA dam-
age repair (Fig. 4B, 4C). These mechanisms appear to be
more robust in EC cells than in their differentiated counter-
parts. Therefore, we postulate that the S and G2 checkpoints,
as well as DNA repair and apoptosis, operate together in the
maintenance of genome stability for stem cells.
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A short G1-phase and the absence of G1 DNA damage check-
point are the special cell cycle features common in mouse ES,
rhesus monkey ES, and human EC cells (present study). Human
EC cells undergo prominent S-phase delay followed by G2
arrest in response to IR. After differentiation, cells mainly dis-
play a G2 arrest, due to the low expression of cyclin E and
cyclin E/CDK2 complex. Thus, given that the absence of a G1
checkpoint serves a physiological need for self renewal of ES
cells, the S and G2 cell cycle checkpoints, in combination with
more efﬁcient DNA damage repair, are necessary for the main-
tenance of genome integrity in stem cells.
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